Ambikem Biolabs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -7.15%
- Profit Growth 83.76%
- Ebitda 87.42%
- Net Worth -21.77%
- Total Assets -25.38%
About Ambikem Biolabs
Ambikem Biolabs Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 October 2017 (Seven years and three months 20 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Chandra Singh, Pankaj Gautam, and Birendra Kumar serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2017PTC325118
-
Company No.
325118
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Oct 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Ambikem Biolabs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Singh
|
Director | 18-Oct-2017 | Current |
|
Pankaj Gautam
|
Additional Director | 24-Aug-2023 | Current |
|
Birendra Kumar
|
Director | 18-Oct-2017 | Current |
Financial Performance of Ambikem Biolabs.
Ambikem Biolabs Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 7.15% decrease. The company also saw a substantial improvement in profitability, with a 83.76% increase in profit. The company's net worth observed a substantial decline by a decrease of 21.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ambikem Biolabs?
Unlock access to Ambikem Biolabs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Connecting Works Private LimitedBirendra Kumar is a mutual person
-
Mediq Hospital Private Limited
Birendra Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ambikem Biolabs?
Unlock and access historical data on people associated with Ambikem Biolabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ambikem Biolabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ambikem Biolabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
